Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
X
Announcing the new Tapestri scMRD Assay for AML. Learn More
X
Scientific presentation

Unraveling clonal heterogeneity and evolutionary history of AML by single-cell DNA sequencing


Koichi Takahashi, MD
Description

Dr. Takahashi from MD Anderson Cancer Center presents his findings using single-cell sequencing from a study of 70 AML patients demonstrating clonal remodeling at relapse. Furthermore, divergent clones with a shared functionality were inferred by reconstructing the phylogeny of driver mutations in AML. Through single-cell analysis, which had 100% concordance with bulk sequencing, he visualized the co-occurrence of foundation mutations to identify cancer driver genes. In this presentation, he shows, through mutation tracking, that clonal heterogeneity is a reflection of how each clone evolves under pressure of the cancer ecosystem and treatment.



VIEW


Scientific presentation
AML Single-cell Multi-omics MRD (scMRD) and the Horizon of Clinical Utility
Aaron Llanso
AMP 2022 (2022)
Scientific presentation
Molecular Analysis of Acute Myeloid Leukemia in Morphologic Remission
Sanam Loghavi, MD
AMP 2022 (2022)
Scientific presentation
Considerations, Strategies, and Advances in Early Drug Development to Mitigate Clinical Holds and Achieve Successful CGT Outcomes
Azadeh Golipour, PhD, AVROBIO
J. Kelly Ganjei, AmplifyBio
Scott R. Burger, MD, Advanced Cell and Gene Therapy
Matthew Cato
(2022)
Scientific presentation
Overview on Mission Bio’s Applications
Simone Formisano
Mission Bio EU Heme Symposium (2022)
REQUEST QUOTE